Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Dansk France Français Finland Suomi Suomalainen Germany Deutschland Deutsch Greece Ελλάδα Ελληνικά Ireland English Italy Italia Italiano Netherlands Nederland Nederlands Norway Norge Norsk Poland Polska Polskie Portugal Português ...
The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
Industry:Pharmaceuticals CEO:Reshma Kewalramani Website:https://www.vrtx.com/ Ticker:VRTX Company type:Public Revenues ($M):$9,869 Profits ($M):$3,620 Market value ($M):$107,975 Number of employees:5,236 Market value as of March 28, 2024.Vertex Pharmaceuticals stock chartVertex...
Global resources for medical professionals. Learn more about Vertex's grants & funding opportunities, research & development, clinical trials, CF Foundation & more.